Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Eterna Therapeutics Inc.

    NASDAQ: ERNA · Real-Time Price · USD
    2.29
    -0.08 (-3.38%)
    At close: Jun 13, 2025, 3:59 PM
    2.35
    2.84%
    After-hours: Jun 13, 2025, 05:05 PM EDT

    Eterna Therapeutics Statistics

    Share Statistics

    Eterna Therapeutics has 62.36M shares outstanding. The number of shares has increased by -1.63% in one year.

    Shares Outstanding

    n/a
    		 62.36M

    Shares Change (YoY)

    n/a
    		 -1.63%

    Shares Change (QoQ)

    n/a
    		 -1.65%

    Owned by Institutions (%)

    n/a
    		 7.29%

    Shares Floating

    n/a
    		 791.41K

    Failed to Deliver (FTD) Shares

    n/a
    		 25

    FTD / Avg. Volume

    n/a
    		 0.01%

    Short Selling Information

    The latest short interest is 127.42K, so 0.2% of the outstanding shares have been sold short.

    Short Interest

    n/a
    		 127.42K

    Short % of Shares Out

    n/a
    		 0.2%

    Short % of Float

    n/a
    		 0.31%

    Short Ratio (days to cover)

    n/a
    		 1

    Valuation Ratios

    The PE ratio is -0.09 and the forward PE ratio is -0.02. Eterna Therapeutics's PEG ratio is 0.

    PE Ratio

    n/a
    		 -0.09

    Forward PE

    n/a
    		 -0.02

    PS Ratio

    n/a
    		 6.89

    Forward PS

    n/a
    		 0.2

    PB Ratio

    n/a
    		 2.36

    P/FCF Ratio

    n/a
    		 -0.25

    PEG Ratio

    n/a
    		 0
    Financial Ratio History

    Enterprise Valuation

    Currently the Enterprise Value (EV) is not available for Eterna Therapeutics.

    EV / Sales

    n/a
    		 n/a

    EV / EBITDA

    n/a
    		 n/a

    EV / EBIT

    n/a
    		 n/a

    EV / FCF

    n/a
    		 n/a

    Financial Position

    The company has a current ratio of 0.8, with a Debt / Equity ratio of 0.4.

    Current Ratio

    n/a
    		 0.8

    Quick Ratio

    n/a
    		 0.8

    Debt / Equity

    n/a
    		 0.4

    Debt / EBITDA

    n/a
    		 -0.02

    Debt / FCF

    n/a
    		 -0.04

    Interest Coverage

    n/a
    		 -2.32

    Financial Efficiency

    Return on Equity is n/a and Return on Invested Capital is n/a.

    Return on Equity

    n/a
    		 n/a

    Return on Assets

    n/a
    		 n/a

    Return on Invested Capital

    n/a
    		 n/a

    Revenue Per Employee

    n/a
    		 $97,000

    Profits Per Employee

    n/a
    		 $-7,423,166.67

    Employee Count

    n/a
    		 6

    Asset Turnover

    n/a
    		 0.11

    Inventory Turnover

    n/a
    		 n/a

    Taxes

    Income Tax

    n/a
    		 30K

    Effective Tax Rate

    n/a
    		 -0.07%

    Stock Price Statistics

    The stock price has increased by -99.36% in the last 52 weeks. The beta is 7.12, so Eterna Therapeutics's price volatility has been higher than the market average.

    Beta

    n/a
    		 7.12

    52-Week Price Change

    n/a
    		 -99.36%

    50-Day Moving Average

    n/a
    		 3.03

    200-Day Moving Average

    n/a
    		 8.5

    Relative Strength Index (RSI)

    n/a
    		 32.7

    Average Volume (20 Days)

    n/a
    		 270,784

    Income Statement

    In the last 12 months, Eterna Therapeutics had revenue of 582K and earned -44.54M in profits. Earnings per share was -3.26.

    Revenue

    n/a
    		 582K

    Gross Profit

    n/a
    		 486K

    Operating Income

    n/a
    		 -15.67M

    Net Income

    n/a
    		 -44.54M

    EBITDA

    n/a
    		 -36.12M

    EBIT

    n/a
    		 -37.76M

    Earnings Per Share (EPS)

    n/a
    		 -3.26
    Full Income Statement

    Balance Sheet

    The company has 1.73M in cash and 684K in debt, giving a net cash position of 1.04M.

    Cash & Cash Equivalents

    n/a
    		 1.73M

    Total Debt

    n/a
    		 684K

    Net Cash

    n/a
    		 1.04M

    Retained Earnings

    n/a
    		 -231.54M

    Total Assets

    n/a
    		 5.06M

    Working Capital

    n/a
    		 -8.23M
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was -15.84M and capital expenditures -369K, giving a free cash flow of -16.2M.

    Operating Cash Flow

    n/a
    		 -15.84M

    Capital Expenditures

    n/a
    		 -369K

    Free Cash Flow

    n/a
    		 -16.2M

    FCF Per Share

    n/a
    		 -1.19
    Full Cash Flow Statement

    Margins

    Gross margin is 83.51%, with operating and profit margins of -2693.13% and -7652.75%.

    Gross Margin

    n/a
    		 83.51%

    Operating Margin

    n/a
    		 -2693.13%

    Pretax Margin

    n/a
    		 -7647.59%

    Profit Margin

    n/a
    		 -7652.75%

    EBITDA Margin

    n/a
    		 -6206.01%

    EBIT Margin

    n/a
    		 -2693.13%

    FCF Margin

    n/a
    		 -2784.36%

    Dividends & Yields

    ERNA does not appear to pay any dividends at this time.

    Dividend Per Share

    n/a
    		 n/a

    Dividend Yield

    n/a
    		 n/a

    Dividend Growth (YoY)

    n/a
    		 n/a

    Payout Ratio

    n/a
    		 n/a

    Earnings Yield

    n/a
    		 n/a

    FCF Yield

    n/a
    		 n/a
    Dividend Details

    Analyst Forecast

    Currently there are no analyst rating for ERNA.

    Price Target

    n/a
    		 n/a

    Price Target Difference

    n/a
    		 n/a

    Analyst Consensus

    n/a
    		 n/a

    Analyst Count

    n/a
    		 n/a
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 n/a

    Lynch Upside

    n/a
    		 n/a

    Graham Number

    n/a
    		 n/a

    Graham Upside

    n/a
    		 n/a

    Stock Splits

    The last stock split was on Jun 12, 2025. It was a backward split with a ratio of 1:15.

    Last Split Date

    n/a
    		 Jun 12, 2025

    Split Type

    n/a
    		 backward

    Split Ratio

    n/a
    		 1:15

    Scores

    Altman Z-Score

    n/a
    		 -90.16

    Piotroski F-Score

    n/a
    		 4

    Add to Watchlist